
Anna Kathy Aman
Examiner (ID: 18092, Phone: (571)272-4515 , Office: P/2914 )
| Most Active Art Unit | 2914 |
| Art Unit(s) | 2914, 2973 |
| Total Applications | 3318 |
| Issued Applications | 3249 |
| Pending Applications | 17 |
| Abandoned Applications | 54 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8313699
[patent_doc_number] => 20120190717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'METHODS AND COMPOSITIONS FOR INCREASING THE ANAEROBIC WORKING CAPACITY IN TISSUES'
[patent_app_type] => utility
[patent_app_number] => 13/356182
[patent_app_country] => US
[patent_app_date] => 2012-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 11782
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13356182
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/356182 | Methods and compositions for increasing the anaerobic working capacity in tissues | Jan 22, 2012 | Issued |
Array
(
[id] => 9463970
[patent_doc_number] => 20140128397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'SYNTHETIC LETHAL TARGETING OF GLUCOSE TRANSPORT'
[patent_app_type] => utility
[patent_app_number] => 13/980565
[patent_app_country] => US
[patent_app_date] => 2012-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19167
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980565
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/980565 | Synthetic lethal targeting of glucose transport | Jan 19, 2012 | Issued |
Array
(
[id] => 9122186
[patent_doc_number] => 20130289108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'Palladium-Copper Catalysts for the Homogeneous Selective Oxidation of Thiol Groups'
[patent_app_type] => utility
[patent_app_number] => 13/978936
[patent_app_country] => US
[patent_app_date] => 2011-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14632
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978936
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/978936 | Palladium-Copper Catalysts for the Homogeneous Selective Oxidation of Thiol Groups | Dec 29, 2011 | Abandoned |
Array
(
[id] => 8510429
[patent_doc_number] => 20120309837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-06
[patent_title] => 'Bronchodilating Beta-Agonist Compositions and Methods'
[patent_app_type] => utility
[patent_app_number] => 13/336972
[patent_app_country] => US
[patent_app_date] => 2011-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10208
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13336972
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/336972 | Bronchodilating Beta-agonist compositions and methods | Dec 22, 2011 | Issued |
Array
(
[id] => 8159037
[patent_doc_number] => 20120100529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'Biological Specimen Collection and Transport System and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 13/332204
[patent_app_country] => US
[patent_app_date] => 2011-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 16081
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20120100529.pdf
[firstpage_image] =>[orig_patent_app_number] => 13332204
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/332204 | Biological specimen collection and transport system and methods of use | Dec 19, 2011 | Issued |
Array
(
[id] => 9817795
[patent_doc_number] => 08927580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-06
[patent_title] => 'Thiosemicarbazone compounds and use in the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 13/994355
[patent_app_country] => US
[patent_app_date] => 2011-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14098
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13994355
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/994355 | Thiosemicarbazone compounds and use in the treatment of cancer | Dec 15, 2011 | Issued |
Array
(
[id] => 9339627
[patent_doc_number] => 20140066409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'CYCLOHEXANE COMPOUNDS AND THEIR USE AS ANTIBIOTICS'
[patent_app_type] => utility
[patent_app_number] => 13/990801
[patent_app_country] => US
[patent_app_date] => 2011-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17050
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13990801
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/990801 | Cyclohexane compounds and their use as antibiotics | Dec 12, 2011 | Issued |
Array
(
[id] => 8141675
[patent_doc_number] => 20120095388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'MATERIAL FOR FACILITATING THERMAL TREATMENTS OF BIOLOGICAL TISSUES AND METHOD OF ENERGY TARGETING LEADING TO THERMAL TREATMENT OF BIOLOGICAL TISSUES'
[patent_app_type] => utility
[patent_app_number] => 13/311025
[patent_app_country] => US
[patent_app_date] => 2011-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11972
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20120095388.pdf
[firstpage_image] =>[orig_patent_app_number] => 13311025
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/311025 | Material for facilitating thermal treatments of biological tissues and method of energy targeting leading to thermal treatment of biological tissues | Dec 4, 2011 | Issued |
Array
(
[id] => 9483121
[patent_doc_number] => 08729073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-20
[patent_title] => '5-methyl-1-(naphthalen-2-yl)-1H-pyrazole derivatives and their use in potentiating the effect of opioid analgesics'
[patent_app_type] => utility
[patent_app_number] => 13/991267
[patent_app_country] => US
[patent_app_date] => 2011-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6175
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13991267
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/991267 | 5-methyl-1-(naphthalen-2-yl)-1H-pyrazole derivatives and their use in potentiating the effect of opioid analgesics | Dec 1, 2011 | Issued |
Array
(
[id] => 9069392
[patent_doc_number] => 20130261148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'PROTECTED ANTIMICROBIAL COMPOUNDS FOR HIGH TEMPERATURE APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/993523
[patent_app_country] => US
[patent_app_date] => 2011-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2964
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993523
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/993523 | Protected antimicrobial compounds for high temperature applications | Dec 1, 2011 | Issued |
Array
(
[id] => 8053997
[patent_doc_number] => 20120076733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'POST-BIOPSY CAVITY TREATMENT IMPLANTS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/309504
[patent_app_country] => US
[patent_app_date] => 2011-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 16112
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20120076733.pdf
[firstpage_image] =>[orig_patent_app_number] => 13309504
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/309504 | POST-BIOPSY CAVITY TREATMENT IMPLANTS AND METHODS | Nov 30, 2011 | Abandoned |
Array
(
[id] => 8312514
[patent_doc_number] => 20120189537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'NITRILE DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/302409
[patent_app_country] => US
[patent_app_date] => 2011-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14799
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13302409
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/302409 | Nitrile derivatives and their pharmaceutical use and compositions | Nov 21, 2011 | Issued |
Array
(
[id] => 8043417
[patent_doc_number] => 20120071446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'DOSAGE REGIMEN OF AN S1P RECEPTOR AGONIST'
[patent_app_type] => utility
[patent_app_number] => 13/302881
[patent_app_country] => US
[patent_app_date] => 2011-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4940
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20120071446.pdf
[firstpage_image] =>[orig_patent_app_number] => 13302881
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/302881 | DOSAGE REGIMEN OF AN S1P RECEPTOR AGONIST | Nov 21, 2011 | Abandoned |
Array
(
[id] => 9192139
[patent_doc_number] => 20130331454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'PKC-EPSILON ACTIVATOR'
[patent_app_type] => utility
[patent_app_number] => 13/885751
[patent_app_country] => US
[patent_app_date] => 2011-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12836
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13885751
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/885751 | PKC-ε activator | Nov 14, 2011 | Issued |
Array
(
[id] => 9191010
[patent_doc_number] => 20130330326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'METHODS OF TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/884842
[patent_app_country] => US
[patent_app_date] => 2011-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 22189
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884842
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/884842 | Methods of treating cancer | Nov 10, 2011 | Issued |
Array
(
[id] => 9149091
[patent_doc_number] => 20130303614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'AGENT FOR INHIBITING ELEVATION IN BLOOD GLUCOSE LEVEL'
[patent_app_type] => utility
[patent_app_number] => 13/884089
[patent_app_country] => US
[patent_app_date] => 2011-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4414
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884089
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/884089 | AGENT FOR INHIBITING ELEVATION IN BLOOD GLUCOSE LEVEL | Nov 7, 2011 | Abandoned |
Array
(
[id] => 8199502
[patent_doc_number] => 20120122922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'COMPOSITIONS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE'
[patent_app_type] => utility
[patent_app_number] => 13/290491
[patent_app_country] => US
[patent_app_date] => 2011-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8010
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20120122922.pdf
[firstpage_image] =>[orig_patent_app_number] => 13290491
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/290491 | COMPOSITIONS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE | Nov 6, 2011 | Abandoned |
Array
(
[id] => 8171389
[patent_doc_number] => 20120107404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'Crystalline Pharmaceutical and Methods of Preparation and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/289172
[patent_app_country] => US
[patent_app_date] => 2011-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 57361
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20120107404.pdf
[firstpage_image] =>[orig_patent_app_number] => 13289172
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/289172 | Crystalline pharmaceutical and methods of preparation and use thereof | Nov 3, 2011 | Issued |
Array
(
[id] => 10648206
[patent_doc_number] => 09364430
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-14
[patent_title] => 'Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14-diol'
[patent_app_type] => utility
[patent_app_number] => 13/882370
[patent_app_country] => US
[patent_app_date] => 2011-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 133867
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882370
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/882370 | Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14-diol | Oct 30, 2011 | Issued |
Array
(
[id] => 11242585
[patent_doc_number] => 09468612
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-18
[patent_title] => 'Cysteamine in the treatment of fibrotic disease'
[patent_app_type] => utility
[patent_app_number] => 14/353273
[patent_app_country] => US
[patent_app_date] => 2011-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 28
[patent_no_of_words] => 17826
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14353273
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/353273 | Cysteamine in the treatment of fibrotic disease | Oct 25, 2011 | Issued |